{"id":5716,"date":"2024-05-14T08:49:19","date_gmt":"2024-05-14T13:49:19","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=5716"},"modified":"2025-06-27T11:17:42","modified_gmt":"2025-06-27T16:17:42","slug":"nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ja\/2024\/05\/14\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\/","title":{"rendered":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u3001\u30ab\u30f3\u30c0\u30f3\u30fb\u30d0\u30e9\u30c0\u30e9\u30f3\u3092\u898f\u5236\u30fb\u54c1\u8cea\u62c5\u5f53\u4e0a\u7d1a\u526f\u793e\u9577\u306b\u4efb\u547d"},"content":{"rendered":"<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<div class=\"col-sm-8 col-vcenter col-xs-12\"><\/div>\n<\/div>\n<\/div>\n<article class=\"news-release inline-gallery-template\">\n<section class=\"release-body container\">\n<div class=\"row\">\n<div class=\"col-lg-10 col-lg-offset-1\">\n<p>\u30c6\u30ad\u30b5\u30b9\u5dde\u30c0\u30e9\u30b9\uff082024\u5e745\u670814\u65e5\uff09\u2014 <a href=\"https:\/\/nanostherapeutics.com\/ja\/\">\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u682a\u5f0f\u4f1a\u793e<\/a>\u907a\u4f1d\u6027\u7db2\u819c\u75be\u60a3\u304a\u3088\u3073\u52a0\u9f62\u6027\u9ec4\u6591\u5909\u6027\u75c7\uff08AMD\uff09\u306b\u5bfe\u3059\u308b\u907a\u4f1d\u5b50\u6cbb\u7642\u3092\u958b\u767a\u3057\u3066\u3044\u308b\u5f8c\u671f\u81e8\u5e8a\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3067\u3042\u308b\u306f\u3001\u672c\u65e5\u3001\u30ab\u30f3\u30c0\u30f3\u30fb\u30d0\u30e9\u30c0\u30e9\u30f3\u535a\u58eb\u3092\u898f\u5236\u304a\u3088\u3073\u54c1\u8cea\u62c5\u5f53\u4e0a\u7d1a\u526f\u793e\u9577\u306b\u4efb\u547d\u3057\u305f\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u30d0\u30e9\u30c0\u30e9\u30f3\u535a\u58eb\u306f\u3001\u898f\u5236\u306b\u95a2\u3059\u308b\u5316\u5b66\u3001\u88fd\u9020\u3001\u304a\u3088\u3073\u7ba1\u7406\uff08CMC\uff09\u306e\u7d4c\u9a13\u3092\u542b\u3080\u3001\u907a\u4f1d\u5b50\u6cbb\u7642\u88fd\u54c1\u306e\u88fd\u9020\u304a\u3088\u3073\u898f\u5236\u5be9\u67fb\u306b\u304a\u3044\u3066\u7d0420\u5e74\u306b\u308f\u305f\u308b\u8c4a\u5bcc\u306a\u7d4c\u9a13\u3092\u6301\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u300c\u5e0c\u5c11\u907a\u4f1d\u6027\u75be\u60a3\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f01\u696d\u3067\u54c1\u8cea\u3068\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3092\u4e3b\u5c0e\u3057\u3066\u304d\u305f\u30ab\u30f3\u30c0\u30f3\u306e\u7d4c\u9a13\u306f\u3001\u5f53\u793e\u306e\u30d7\u30ed\u30b0\u30e9\u30e0\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u306e\u62e1\u5927\u3092\u63a8\u9032\u3059\u308bMCO-010\u3092\u542b\u3080\u591a\u7528\u9014MCO\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306e\u9032\u5316\u3092\u7d9a\u3051\u308b\u4e0a\u3067\u8cb4\u91cd\u306a\u3082\u306e\u3068\u306a\u308b\u3067\u3057\u3087\u3046\u3002\u3053\u306e\u4efb\u547d\u306f\u3001\u7db2\u819c\u75be\u60a3\u3067\u5931\u660e\u3057\u305f\u4f55\u767e\u4e07\u4eba\u3082\u306e\u4eba\u3005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u3001\u5909\u7570\u306b\u4f9d\u5b58\u3057\u306a\u3044\u6cbb\u7642\u6cd5\u306e\u7d99\u7d9a\u7684\u306a\u9032\u5316\u3092\u30b5\u30dd\u30fc\u30c8\u3059\u308b\u3082\u306e\u3067\u3042\u308a\u3001\u4f01\u696d\u3068\u3057\u3066\u306e\u7d99\u7d9a\u7684\u306a\u6210\u9577\u3092\u5f37\u8abf\u3059\u308b\u3082\u306e\u3067\u3059\u300d\u3068\u3001\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u306e\u5171\u540c\u5275\u8a2d\u8005\u517c\u6700\u9ad8\u7d4c\u55b6\u8cac\u4efb\u8005\u3067\u3042\u308b\u30b9\u30e9\u30b0\u30ca\u30fb\u30d0\u30c3\u30bf\u30c1\u30e3\u30ea\u30e4\u306f\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u201c\u300c\u7db2\u819c\u5909\u6027\u75be\u60a3\u306e\u6cbb\u7642\u306b\u304a\u3051\u308b\u9769\u65b0\u7684\u306a\u30a2\u30d7\u30ed\u30fc\u30c1\u306e\u958b\u767a\u306b\u53d6\u308a\u7d44\u3080\u3001\u610f\u6b32\u306e\u9ad8\u3044Nanoscope\u306e\u30c1\u30fc\u30e0\u306b\u52a0\u308f\u308b\u3053\u3068\u304c\u3067\u304d\u3001\u5927\u5909\u5149\u6804\u306b\u601d\u3044\u307e\u3059\u300d\u3068\u30d0\u30e9\u30c0\u30e9\u30f3\u535a\u58eb\u306f\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\uff08RP\uff09\u3092\u5bfe\u8c61\u3068\u3057\u305f\u7121\u4f5c\u70ba\u5316\u6bd4\u8f03\u8a66\u9a13\u3067\u3001\u6301\u7d9a\u7684\u306a\u6709\u52b9\u6027\u3068\u5b89\u5168\u6027\u304c\u76ee\u899a\u307e\u3057\u3044\u7d50\u679c\u3092\u793a\u3057\u305f\u3053\u3068\u3092\u53d7\u3051\u3001\u4eca\u5f8c\u63a7\u3048\u3066\u3044\u308b\u898f\u5236\u4e0a\u306e\u91cd\u8981\u306a\u7bc0\u76ee\u3092\u4e57\u308a\u8d8a\u3048\u3001\u5546\u696d\u5316\u306b\u5411\u3051\u305f\u6e96\u5099\u3092\u9032\u3081\u308b\u4e2d\u3067\u3001Nanoscope\u306e\u767a\u5c55\u306b\u8ca2\u732e\u3067\u304d\u308b\u3053\u3068\u3092\u5fc3\u5f85\u3061\u306b\u3057\u3066\u3044\u307e\u3059\u3002\u300d\u201d<\/p>\n<p>\u30d0\u30e9\u30c0\u30e9\u30f3\u535a\u58eb\u306f\u3001\u6700\u8fd1\u307e\u3067\u3001\u5e0c\u5c11\u304a\u3088\u3073\u8d85\u5e0c\u5c11\u907a\u4f1d\u5b50\u75be\u60a3\u306e\u6cbb\u7642\u306e\u305f\u3081\u306e\u65b0\u88fd\u54c1\u306e\u7814\u7a76\u958b\u767a\u306b\u643a\u308f\u308b\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f1a\u793e\u3001Ultragenyx Pharmaceutical Inc. \u306e\u898f\u5236 CMC \u62c5\u5f53\u526f\u793e\u9577\u3092\u52d9\u3081\u3066\u3044\u307e\u3057\u305f\u3002\u305d\u308c\u4ee5\u524d\u306f\u3001\u5e0c\u5c11\u75be\u60a3\u306e\u65b0\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u306b\u6ce8\u529b\u3059\u308b\u907a\u4f1d\u5b50\u6cbb\u7642\u4f1a\u793e\u3001Dimension Therapeutics \u306e\u526f\u793e\u9577\u517c\u54c1\u8cea\u8cac\u4efb\u8005\u3092\u52d9\u3081\u3066\u3044\u307e\u3057\u305f\u3002\u305d\u308c\u4ee5\u524d\u306f\u3001\u30d0\u30a4\u30aa\u30b8\u30a7\u30f3\u3001\u30ce\u30d0\u30eb\u30c6\u30a3\u30b9\u3001\u30c0\u30a4\u30a2\u30c3\u30af\u30b9\u3067 CMC \u304a\u3088\u3073\u898f\u5236\u306e\u5f79\u8077\u3092\u52d9\u3081\u3066\u3044\u307e\u3057\u305f\u3002\u30cf\u30fc\u30d0\u30fc\u30c9\u5927\u5b66\u3067\u30a6\u30a4\u30eb\u30b9\u5b66\u306e\u535a\u58eb\u53f7\u3001\u30a6\u30a7\u30eb\u30ba\u30ea\u30fc\u5927\u5b66\u3067\u5206\u5b50\u751f\u7269\u5b66\u306e\u5b66\u58eb\u53f7\u3092\u53d6\u5f97\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p><strong>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u306b\u3064\u3044\u3066<br \/>\n<\/strong>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u306f\u3001\u907a\u4f1d\u6027\u7db2\u819c\u75be\u60a3\u306b\u3088\u308a\u5931\u660e\u3057\u305f\u4f55\u767e\u4e07\u4eba\u3082\u306e\u60a3\u8005\u306e\u305f\u3081\u306b\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u30aa\u30d7\u30c8\u30b8\u30a7\u30cd\u30c6\u30a3\u30c3\u30af\u7642\u6cd5\u3092\u958b\u767a\u3057\u3066\u3044\u308b\u3002\u540c\u793e\u306e\u4e3b\u529b\u88fd\u54c1\u3067\u3042\u308bMCO-010\u306f\u3001 <a href=\"https:\/\/nanostherapeutics.com\/ja\/2024\/03\/26\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\/\">\u6700\u8fd1\u767a\u8868\u3055\u308c\u305f100\u9031\u9593\u306e\u30c7\u30fc\u30bf\u306b\u3088\u308b\u3068\u3001<\/a> \u7c73\u56fd\u306b\u304a\u3051\u308bRP\u306b\u5bfe\u3059\u308bRESTORE\u7b2c2b\/3\u76f8\u591a\u65bd\u8a2d\u30e9\u30f3\u30c0\u30e0\u5316\u4e8c\u91cd\u76f2\u691c\u507d\u5bfe\u7167\u81e8\u5e8a\u8a66\u9a13\uff08<a href=\"https:\/\/c212.net\/c\/link\/?t=0&l=en&o=4009878-1&h=4290035820&u=https:\/\/c212.net\/c\/link\/?t=0&l=en&o=3984630-1&h=517760235&u=https%25253A%25252F%25252Fclinicaltrials.gov%25252Fct2%25252Fshow%25252FNCT04945772%25253Fterm%25253DNanoscope%252526draw%25253D2&a=NCT04945772&a=NCT04945772\">NCT04945772<\/a>\uff09\u3002\u540c\u793e\u306f\u6700\u8fd1\u3001\u30b7\u30e5\u30bf\u30eb\u30ac\u30eb\u30c8\u75c5\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305f MCO-010 \u7642\u6cd5\u306e\u7b2c 2 \u76f8 STARLIGHT \u8a66\u9a13\u3082\u5b8c\u4e86\u3057\u307e\u3057\u305f (<a href=\"https:\/\/c212.net\/c\/link\/?t=0&l=en&o=4009878-1&h=736901417&u=https:\/\/c212.net\/c\/link\/?t=0&l=en&o=3984630-1&h=1090222651&u=https%25253A%25252F%25252Fclinicaltrials.gov%25252Fct2%25252Fshow%25252FNCT05417126%25253Fterm%25253Dnanoscope%252526draw%25253D2%252526rank%25253D3&a=NCT05417126&a=NCT05417126\">NCT05417126<\/a> \uff09\u3002MCO-010 \u306f\u3001RP \u3068\u30b7\u30e5\u30bf\u30eb\u30ac\u30eb\u30c8\u75c5\u306e\u4e21\u65b9\u306b\u5bfe\u3057\u3066 FDA \u306e\u30d5\u30a1\u30b9\u30c8\u30c8\u30e9\u30c3\u30af\u6307\u5b9a\u3068 FDA \u306e\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u524d\u81e8\u5e8a\u8cc7\u7523\u306b\u306f\u3001AMD \u306b\u4f34\u3046\u5730\u56f3\u72b6\u840e\u7e2e\u306b\u5bfe\u3059\u308b\u975e\u30a6\u30a4\u30eb\u30b9\u6027\u30ec\u30fc\u30b6\u30fc\u9001\u9054 MCO-020 \u907a\u4f1d\u5b50\u6cbb\u7642\u304c\u542b\u307e\u308c\u307e\u3059\u3002<\/p>\n<p><strong>\u6295\u8cc7\u5bb6\u9023\u7d61\u5148:<\/strong><br \/>\n\u30a2\u30eb\u30b4\u30c3\u30c8\u30d1\u30fc\u30c8\u30ca\u30fc\u30ba<br \/>\n212-600-1902<br \/>\n<a href=\"mailto:PR@nanostherapeutics.com\">PR@nanostherapeutics.com<\/a><\/p>\n<p>\u51fa\u5178 \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9<\/p>\n<\/div>\n<\/div>\n<\/section>\n<\/article>","protected":false},"excerpt":{"rendered":"<p>DALLAS, TX (May 14, 2024) \u2014 Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for inherited retinal diseases and age-related macular degenerations (AMD), today announced the appointment of Khandan Baradaran, PhD, as Senior Vice President of Regulatory and Quality. Dr. Baradaran brings nearly two decades of extensive experience in manufacturing and regulatory review of gene therapy products, including regulatory Chemistry, Manufacturing, and Controls (CMC) experience. \u201cKhandan\u2019s experience leading quality and compliance for rare genetic disease biopharmaceutical companies will be valuable as we continue to advance our versatile MCO platform, including MCO-010, which is driving our expanding pipeline of programs. This appointment supports the continued advancement of our [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":5720,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-5716","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanoscope Therapeutics Appoints Khandan Baradaran as Senior Vice President of Regulatory and Quality - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ja\/2024\/05\/14\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanoscope Therapeutics Appoints Khandan Baradaran as Senior Vice President of Regulatory and Quality - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ja\/2024\/05\/14\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-14T13:49:19+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-27T16:17:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/05\/NSCOPE_LI_KhandanB_V2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"627\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nanoscope Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/05\/NSCOPE_LI_KhandanB_V2.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nanoscope Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/05\\\/14\\\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/05\\\/14\\\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\\\/\"},\"author\":{\"name\":\"Nanoscope Therapeutics\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\"},\"headline\":\"Nanoscope Therapeutics Appoints Khandan Baradaran as Senior Vice President of Regulatory and Quality\",\"datePublished\":\"2024-05-14T13:49:19+00:00\",\"dateModified\":\"2025-06-27T16:17:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/05\\\/14\\\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\\\/\"},\"wordCount\":424,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/05\\\/14\\\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/NSCOPE_LI_KhandanB_V2.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/05\\\/14\\\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/05\\\/14\\\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\\\/\",\"name\":\"Nanoscope Therapeutics Appoints Khandan Baradaran as Senior Vice President of Regulatory and Quality - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/05\\\/14\\\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/05\\\/14\\\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/NSCOPE_LI_KhandanB_V2.jpg\",\"datePublished\":\"2024-05-14T13:49:19+00:00\",\"dateModified\":\"2025-06-27T16:17:42+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/05\\\/14\\\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/05\\\/14\\\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/05\\\/14\\\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/NSCOPE_LI_KhandanB_V2.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/NSCOPE_LI_KhandanB_V2.jpg\",\"width\":1200,\"height\":627},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/05\\\/14\\\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanoscope Therapeutics Appoints Khandan Baradaran as Senior Vice President of Regulatory and Quality\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\",\"name\":\"Nanoscope Therapeutics\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u30ab\u30f3\u30c0\u30f3\u30fb\u30d0\u30e9\u30c0\u30e9\u30f3\u6c0f\u3092\u898f\u5236\u30fb\u54c1\u8cea\u62c5\u5f53\u4e0a\u7d1a\u526f\u793e\u9577\u306b\u4efb\u547d - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ja\/2024\/05\/14\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\/","og_locale":"ja_JP","og_type":"article","og_title":"Nanoscope Therapeutics Appoints Khandan Baradaran as Senior Vice President of Regulatory and Quality - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ja\/2024\/05\/14\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2024-05-14T13:49:19+00:00","article_modified_time":"2025-06-27T16:17:42+00:00","og_image":[{"width":1200,"height":627,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/05\/NSCOPE_LI_KhandanB_V2.jpg","type":"image\/jpeg"}],"author":"Nanoscope Therapeutics","twitter_card":"summary_large_image","twitter_image":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/05\/NSCOPE_LI_KhandanB_V2.jpg","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u57f7\u7b46\u8005":"Nanoscope Therapeutics","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2024\/05\/14\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2024\/05\/14\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\/"},"author":{"name":"Nanoscope Therapeutics","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2"},"headline":"Nanoscope Therapeutics Appoints Khandan Baradaran as Senior Vice President of Regulatory and Quality","datePublished":"2024-05-14T13:49:19+00:00","dateModified":"2025-06-27T16:17:42+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2024\/05\/14\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\/"},"wordCount":424,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2024\/05\/14\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/05\/NSCOPE_LI_KhandanB_V2.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2024\/05\/14\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\/","url":"https:\/\/nanostherapeutics.com\/2024\/05\/14\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u30ab\u30f3\u30c0\u30f3\u30fb\u30d0\u30e9\u30c0\u30e9\u30f3\u6c0f\u3092\u898f\u5236\u30fb\u54c1\u8cea\u62c5\u5f53\u4e0a\u7d1a\u526f\u793e\u9577\u306b\u4efb\u547d - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2024\/05\/14\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2024\/05\/14\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/05\/NSCOPE_LI_KhandanB_V2.jpg","datePublished":"2024-05-14T13:49:19+00:00","dateModified":"2025-06-27T16:17:42+00:00","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2024\/05\/14\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2024\/05\/14\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/2024\/05\/14\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/05\/NSCOPE_LI_KhandanB_V2.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/05\/NSCOPE_LI_KhandanB_V2.jpg","width":1200,"height":627},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2024\/05\/14\/nanoscope-therapeutics-appoints-khandan-baradaran-as-senior-vice-president-of-regulatory-and-quality\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Nanoscope Therapeutics Appoints Khandan Baradaran as Senior Vice President of Regulatory and Quality"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5e0c\u671b\u306e\u5149\u3092\u53d6\u308a\u623b\u3059","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5716","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/comments?post=5716"}],"version-history":[{"count":3,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5716\/revisions"}],"predecessor-version":[{"id":9045,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5716\/revisions\/9045"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media\/5720"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media?parent=5716"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/categories?post=5716"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/tags?post=5716"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}